日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/02/18 | 3,890 | 3,957 | 3,890 | 3,931 | +25 | +0.6% | 139,700 |
| 2025/02/17 | 4,009 | 4,014 | 3,894 | 3,906 | -122 | -3% | 258,200 |
| 2025/02/14 | 3,920 | 4,028 | 3,900 | 4,028 | +66 | +1.7% | 277,900 |
| 2025/02/13 | 3,915 | 3,980 | 3,891 | 3,962 | +74 | +1.9% | 231,700 |
| 2025/02/12 | 3,934 | 3,983 | 3,864 | 3,888 | -70 | -1.8% | 357,600 |
| 2025/02/10 | 4,000 | 4,053 | 3,871 | 3,958 | +61 | +1.6% | 496,600 |
| 2025/02/07 | 3,882 | 4,016 | 3,868 | 3,897 | -3 | -0.1% | 341,900 |
| 2025/02/06 | 3,889 | 3,914 | 3,861 | 3,900 | +47 | +1.2% | 182,600 |
| 2025/02/05 | 3,800 | 3,873 | 3,787 | 3,853 | +39 | +1% | 191,500 |
| 2025/02/04 | 3,775 | 3,879 | 3,759 | 3,814 | +125 | +3.4% | 358,400 |
| 2025/02/03 | 3,759 | 3,775 | 3,640 | 3,689 | -76 | -2% | 372,400 |
| 2025/01/31 | 3,773 | 3,777 | 3,737 | 3,765 | -7 | -0.2% | 241,200 |
| 2025/01/30 | 3,705 | 3,795 | 3,705 | 3,772 | +72 | +1.9% | 286,600 |
| 2025/01/29 | 3,730 | 3,740 | 3,669 | 3,700 | -41 | -1.1% | 328,100 |
| 2025/01/28 | 3,808 | 3,832 | 3,727 | 3,741 | -54 | -1.4% | 266,000 |
| 2025/01/27 | 3,807 | 3,826 | 3,779 | 3,795 | +4 | +0.1% | 192,800 |
| 2025/01/24 | 3,762 | 3,857 | 3,762 | 3,791 | +22 | +0.6% | 275,100 |
| 2025/01/23 | 3,729 | 3,803 | 3,729 | 3,769 | +6 | +0.2% | 254,900 |
| 2025/01/22 | 3,769 | 3,789 | 3,749 | 3,763 | +15 | +0.4% | 161,300 |
| 2025/01/21 | 3,704 | 3,754 | 3,701 | 3,748 | +11 | +0.3% | 157,700 |
| 2025/01/20 | 3,701 | 3,771 | 3,700 | 3,737 | +30 | +0.8% | 211,600 |
| 2025/01/17 | 3,800 | 3,816 | 3,706 | 3,707 | -113 | -3% | 197,100 |
| 2025/01/16 | 3,834 | 3,864 | 3,820 | 3,820 | +1 | ±0% | 168,600 |
| 2025/01/15 | 3,850 | 3,888 | 3,780 | 3,819 | -58 | -1.5% | 241,300 |
| 2025/01/14 | 3,930 | 3,968 | 3,866 | 3,877 | -81 | -2% | 283,200 |
| 2025/01/10 | 3,980 | 3,994 | 3,941 | 3,958 | -41 | -1% | 188,800 |
| 2025/01/09 | 4,018 | 4,051 | 3,945 | 3,999 | -11 | -0.3% | 223,300 |
| 2025/01/08 | 4,047 | 4,074 | 4,010 | 4,010 | -42 | -1% | 198,400 |
| 2025/01/07 | 4,055 | 4,095 | 4,028 | 4,052 | +16 | +0.4% | 363,200 |
| 2025/01/06 | 3,997 | 4,088 | 3,961 | 4,036 | +47 | +1.2% | 293,900 |
| 2024/12/30 | 3,987 | 4,006 | 3,963 | 3,989 | -18 | -0.4% | 187,800 |
| 2024/12/27 | 3,970 | 4,015 | 3,960 | 4,007 | +76 | +1.9% | 287,600 |
| 2024/12/26 | 3,962 | 3,979 | 3,923 | 3,931 | -57 | -1.4% | 322,500 |
| 2024/12/25 | 4,010 | 4,038 | 3,932 | 3,988 | +6 | +0.2% | 214,300 |
| 2024/12/24 | 3,862 | 4,015 | 3,846 | 3,982 | +133 | +3.5% | 524,600 |
| 2024/12/23 | 4,043 | 4,098 | 3,745 | 3,849 | -334 | -8% | 1,249,100 |
| 2024/12/20 | 4,200 | 4,222 | 4,174 | 4,183 | +26 | +0.6% | 399,000 |
| 2024/12/19 | 4,135 | 4,191 | 4,133 | 4,157 | -32 | -0.8% | 324,800 |
| 2024/12/18 | 4,219 | 4,252 | 4,180 | 4,189 | -2 | ±0% | 290,900 |
| 2024/12/17 | 4,237 | 4,258 | 4,155 | 4,191 | +6 | +0.1% | 314,900 |
| 2024/12/16 | 4,168 | 4,208 | 4,123 | 4,185 | +49 | +1.2% | 289,800 |
| 2024/12/13 | 4,152 | 4,200 | 4,136 | 4,136 | -38 | -0.9% | 271,600 |
| 2024/12/12 | 4,195 | 4,225 | 4,172 | 4,174 | +1 | ±0% | 236,600 |
| 2024/12/11 | 4,210 | 4,229 | 4,141 | 4,173 | -51 | -1.2% | 209,100 |
| 2024/12/10 | 4,258 | 4,271 | 4,191 | 4,224 | -1 | ±0% | 263,100 |
| 2024/12/09 | 4,264 | 4,271 | 4,210 | 4,225 | -19 | -0.4% | 295,100 |
| 2024/12/06 | 4,260 | 4,265 | 4,203 | 4,244 | -16 | -0.4% | 244,700 |
| 2024/12/05 | 4,280 | 4,280 | 4,220 | 4,260 | -6 | -0.1% | 226,500 |
| 2024/12/04 | 4,274 | 4,325 | 4,232 | 4,266 | -67 | -1.5% | 337,600 |
| 2024/12/03 | 4,328 | 4,393 | 4,305 | 4,333 | -12 | -0.3% | 280,600 |
51～
100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 373,500円 | +7.9% | +8.9% | 3.32% | 7.99倍 | 1.07倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ペプチド | 201,800円 | +5.0% | +1.5% | 0.00% | 17.33倍 | 4.61倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 203,300円 | +4.0% | +25.4% | 2.61% | 8.89倍 | 1.17倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 科研薬 | 407,200円 | +30.5% | +111.0% | 4.67% | 11.48倍 | 1.00倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
